Loading viewer...
investor_presentation
Format: PDF investor_presentation
Rocket Pharmaceuticals' investor presentation outlines the company's development of first-in-class and best-in-class curative gene therapies for rare genetic diseases including Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency, and Danon Disease. The deck discusses clinical trial timelines, regulatory strategies, and pipeline advancement plans.
conference
45 Pages
investor_presentation
24 Pages
Macerich
Reviva Pharmaceuticals 2024 Corporate Presentation
investor_presentationinvestor_presentation
38 Pages
Reviva Pharmaceuticals Holdings, Inc.